10,285
Views
68
CrossRef citations to date
0
Altmetric
Antimicrobial Agents

Carbapenemase-producing Pseudomonas aeruginosa –an emerging challenge

, &
Pages 811-814 | Received 27 Jan 2022, Accepted 25 Feb 2022, Published online: 12 Mar 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Christian M. Gill, Poonam Rajkotia, Amity L. Roberts, Fred C. Tenover & David P. Nicolau. (2023) Directed carbapenemase testing is no longer just for Enterobacterales: cost, labor, and workflow assessment of expanding carbapenemase testing to carbapenem-resistant P. aeruginosa. Emerging Microbes & Infections 12:1.
Read now

Articles from other publishers (67)

Katerina Tsilipounidaki, Christos-Georgios Gkountinoudis, Zoi Florou, George C. Fthenakis & Efthymia Petinaki. (2024) In Silico Molecular Analysis of Carbapenemase-Negative Carbapenem-Resistant Pseudomonas aeruginosa Strains in Greece. Microorganisms 12:4, pages 805.
Crossref
Antonio Oliver, Estrella Rojo-Molinero, Jorge Arca-Suarez, Yeşim Beşli, Pierre Bogaerts, Rafael Cantón, Cansu Cimen, Peter D. Croughs, Olivier Denis, Christian G. Giske, Tíscar Graells, Te-Din Daniel Huang, Bogdan I. Iorga, Onur Karatuna, Béla Kocsis, Andreas Kronenberg, Carla López-Causapé, Surbhi Malhotra-Kumar, Luis Martínez Martínez, Annarita Mazzariol, Sylvain Meyer, Thierry Naas, Daan W. Notermans, Jesús Oteo-Iglesias, Torunn Pedersen, Mateja Pirš, Patricia Poeta, Laurent Poirel, Spyros Pournaras, Arnfinn Sundsfjord, Dora Szabó, Arjana Tambić-Andrašević, Rossitza Vatcheva-Dobrevska, Astra Vitkauskienė & Katy Jeannot. (2024) Pseudomonas aeruginosa antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages: update from ESGARS-ESCMID/ISARPAE Group. Clinical Microbiology and Infection 30:4, pages 469-480.
Crossref
Song Zhang, Xinyu Liao, Tian Ding & Juhee Ahn. (2024) Role of β-Lactamase Inhibitors as Potentiators in Antimicrobial Chemotherapy Targeting Gram-Negative Bacteria. Antibiotics 13:3, pages 260.
Crossref
Xiaohua Qin, Li Ding, Min Hao, Pei Li, Fupin Hu & Minggui Wang. (2024) Antimicrobial resistance of clinical bacterial isolates in China: current status and trends. JAC-Antimicrobial Resistance 6:2.
Crossref
Victor H Ruiz, Christian M Gill & David P Nicolau. (2024) Assessing the in vivo impact of novel β-lactamase inhibitors on the efficacy of their partner β-lactams against serine carbapenemase-producing Pseudomonas aeruginosa using human-simulated exposures . Journal of Antimicrobial Chemotherapy 79:3, pages 546-551.
Crossref
Yang Bai, Yan-e Gong, Fangfang Shen, Hui Li, Yan Cheng, Jinying Guo, Guangming Liu & Ai-fang Ji. (2024) Molecular epidemiological characteristics of carbapenem-resistant Pseudomonas aeruginosa clinical isolates in southeast Shanxi, China. Journal of Global Antimicrobial Resistance 36, pages 301-306.
Crossref
Marta Hernández-García, Margarita Cabello, Manuel Ponce-Alonso, Pedro M. Herrador-Gómez, Francesca Gioia, Javier Cobo, Rafael Cantón & Patricia Ruiz-Garbajosa. (2024) First detection in Spain of NDM-1-producing Pseudomonas aeruginosa in two patients transferred from Ukraine to a university hospital. Journal of Global Antimicrobial Resistance 36, pages 105-111.
Crossref
Jacqueline Findlay, Otavio Hallal Ferreira Raro, Laurent Poirel, Patrice Nordmann, R. Lienhard, L. Vonallmen, C. Schilt, A. Scherler, K. Lucke, M. Jutzi, M. Reichmuth, U. Schibli, C. Fricker, S. Pranghofer, G. Greub, D. Blanc, A. Vitale, B. Lemaire, M. Fatoux, M. Tritten, L. Rumebe, N. Liassine, G. Jost, N. Wohlwend, D. Schultze, K. Burren, A. Westers, M. Imperiali, L. Pozzi, D. Balzari, G. Vaninetti, C. Cirillo, V. Gaia, E. Pianezzi, G. Martinetti Lucchini, F. Baggi Menozzi, A. Jayol, C. Guyon, D. Hyden, M. Maitrejean, V. Deggi-Messmer, D. Bandeira, C. Fournier, S. Pfister, C. Nusbaumer, L. Bertaiola Monnerat, J. Schrenzel, G. Renzi, A. Cherkaoui, D. Andrey, S. Emonet, M. Eyer, R. Maret, A. Belo, D. Mabillard, M. Moraz, K. Herzog, V. Gisler, E. Hitz, M. Oberle, C. Castelberg, H. Fankhauser, S. Graf, N. Dubey, C. Guler, M. Schoenenberger, U. Karrer, F. Piran, C. Andreutti, M. Dessauges, T. Schmid, B. Suterbuser, I. Mitrovic, E. Gruner, V. Bruderer, P. Staehli, B. Schnell, C. O. Marti, I. Steffen, A. Imhof, B. Preiswerk, V. Dilorenzo, C. Payen, D. Boschung, L. Comte, M. Schacher, M. Brandenberger, C. Zowa, C. Zehnder, B. Mathis, L. Basilico, G. Togni, P. Minkova, Y. Born, M. Kuegler, V. Povolo, S. Droz, M. Elzi, C. Casanova, D. Goldenberger, P. Keller, C. Lang, A. Blaich, S. Schmid, B. Ivan, A. Egli, S. Mancini, O. Dubois, K. Narr, S. Schoch, S. Ellenberger & S. Seiffert. (2024) Molecular analysis of metallo-beta-lactamase-producing Pseudomonas aeruginosa in Switzerland 2022–2023. European Journal of Clinical Microbiology & Infectious Diseases 43:3, pages 551-557.
Crossref
Luozhu Feng, Huanchang Chen, Changrui Qian, Yining Zhao, Weixiang Wang, Yan Liu, Mengxin Xu, Jianming Cao, Tieli Zhou & Qing Wu. (2024) Resistance, mechanism, and fitness cost of specific bacteriophages for Pseudomonas aeruginosa . mSphere 9:2.
Crossref
Tracey L. Bonfield, Sean T. Zuckerman, Morgan T. Sutton, Julius N. Korley & Horst A. von Recum. (2024) Polymerized cyclodextrin microparticles for sustained antibiotic delivery in lung infections. Journal of Biomedical Materials Research Part A.
Crossref
Aamir Jamal Gondal, Nakhshab Choudhry, Ammara Niaz & Nighat Yasmin. (2024) Molecular Analysis of Carbapenem and Aminoglycoside Resistance Genes in Carbapenem-Resistant Pseudomonas aeruginosa Clinical Strains: A Challenge for Tertiary Care Hospitals. Antibiotics 13:2, pages 191.
Crossref
Maoling Luo, Si Li & Wenying Luo. (2024) Comparative analysis of antibiotic susceptibility patterns and clinical features of mucoid and non-mucoid Pseudomonas aeruginosa infections: a retrospective study. Frontiers in Public Health 12.
Crossref
Alina Maria Borcan, Georgiana Radu, Mădălina Simoiu, Elena Liliana Costea & Alexandru Rafila. (2024) A Five-Year Analysis of Antibiotic Resistance Trends among Bacteria Identified in Positive Urine Samples in a Tertiary Care Hospital from Bucharest, Romania. Antibiotics 13:2, pages 160.
Crossref
Yuhui Yang, Li Zhang, Jian Wang, Zongyue Chen, Liang Tong, Zhenkun Wang, Gaoming Li & Yu Luo. (2024) Proportions of Pseudomonas aeruginosa and Antimicrobial-Resistant P aeruginosa Among Patients With Surgical Site Infections in China: A Systematic Review and Meta-analysis . Open Forum Infectious Diseases 11:2.
Crossref
Christian M Gill, Debora Santini, David P Nicolau, Elif Aktas, Wadha Alfouzan, Lori Bourassa, Adrian Brink, Carey-Ann D Burnham, Rafael Canton, Yehuda Carmeli, Marco Falcone, Carlos Kiffer, Anna Marchese, Octavio Martinez, Spyros Pournaras, Michael Satlin, Harald Seifert, Abrar K Thabit, Kenneth S Thomson, Maria Virginia Villegas, Julia Wille, Thais Teles Freitas Rezende, Zuhal Cekin, Gulsah Malkocoglu, Desirèe Gijón, Layla Abdullah Tarakmeh, Chun Yat Chu, Christoffel Johannes Opperman, Hafsah Deepa Tootla, Clinton Moodley, Jennifer Coetzee, Sophia Vourli, George Dimopoulos, Dalya M Attallah, Giusy Tiseo, Alessandro Leonildi, Cesira Giordano, Simona Barnini, Francesco Menichetti, Vincenzo Di Pilato, Giulia Codda, Antonio Vena, Daniele Roberto Giacobbe, Lars Westblade, Armando Cardona, Lauren Curtis, Ferric Fang & Gina Thomson. (2024) In vitro activity of cefiderocol against a global collection of carbapenem-resistant Pseudomonas aeruginosa with a high level of carbapenemase diversity . Journal of Antimicrobial Chemotherapy 79:2, pages 412-416.
Crossref
Haitao Yang, Aibo Liu, Fenfen Ma, Xuzhu Gao, Kun Wang & Yan Wang. (2024) Establishment of portable Pseudomonas aeruginosa detection platform based on one-tube CRISPR/Cas12a combined with recombinase polymerase amplification technology. Clinica Chimica Acta 554, pages 117760.
Crossref
Mulatu Gashaw, Esayas Kebede Gudina, Solomon Ali, Liegl Gabriele, Thomas Seeholzer, Bikila Alemu, Guenter Froeschl, Arne Kroidl & Andreas Wieser. (2024) Molecular characterization of carbapenem-resistance in Gram-negative isolates obtained from clinical samples at Jimma Medical Center, Ethiopia. Frontiers in Microbiology 15.
Crossref
María A. Gomis-Font, María A. Clari, Carla López-Causapé, David Navarro & Antonio Oliver. (2024) Emergence of cefiderocol resistance during ceftazidime/avibactam treatment caused by a large genomic deletion, including ampD and piuCD genes, in Pseudomonas aeruginosa . Antimicrobial Agents and Chemotherapy 68:1.
Crossref
Seri Jeong, Kibum Jeon, Nuri Lee, Min-Jeong Park & Wonkeun Song. (2023) Changing Genotypic Distribution, Antimicrobial Susceptibilities, and Risk Factors of Urinary Tract Infection Caused by Carbapenemase-Producing Pseudomonas aeruginosa . Annals of Laboratory Medicine 44:1, pages 38-46.
Crossref
Ameera Aisyah Azman, Adam Thean Chor Leow, Noor Dina Muhd Noor, Siti Aminah Mohd Noor, Wahhida Latip & Mohd Shukuri Mohamad Ali. (2024) Worldwide trend discovery of structural and functional relationship of metallo-β-lactamase for structure-based drug design: A bibliometric evaluation and patent analysis. International Journal of Biological Macromolecules 256, pages 128230.
Crossref
Stefania Mercadante, Costanza Tripiciano, Lorenza Romani, Matteo Di Nardo, Gabriella Bottari, Bianca Maria Goffredo, Raffaele Simeoli, Isabella Guzzo, Laura Lancella, Charalampos Antachopoulos & Maia De Luca. (2023) The Use of Cefiderocol as Salvage Therapy in an Infant Receiving ECMO and Continuous Renal Replacement Therapy. Antibiotics 13:1, pages 37.
Crossref
N. Bahniuk, M. Faustova, K. Riesbeck, Z. Prokopchuk, V. Paliy, O. Nazarchuk & G. Loban. (2023) THE CORRESPONDENCE OF THE CARBAPENEMASE GENOTYPE AND PHENOTYPIC ANTIMICROBIAL PROFILES OF PSEUDOMONAS AERUGINOSA. The Medical and Ecological Problems 27:5-6, pages 45-50.
Crossref
Miyoung Lee. (2023) Emergence of Conjugative Multidrug-Resistant Pseudomonas aeruginosa . Microbiology and Biotechnology Letters 51:4, pages 517-525.
Crossref
Laura Biez, Rémy A. Bonnin, Cecile Emeraud, Aurélien Birer, Agnès B. Jousset, Thierry Naas & Laurent Dortet. (2023) Nationwide molecular epidemiology of carbapenemase-producing Citrobacter spp. in France in 2019 and 2020 . mSphere 8:6.
Crossref
Xiaotong Gu, Weijin Chen, Ting Guo, Xiaohong Chang, Shenyan Zhang, Bingfang Bai & Shutao Ma. (2024) A novel synthetic method for backbone-cyclized polypeptide POL7080 with the help of hydrophobic-support materials. Organic & Biomolecular Chemistry 22:1, pages 85-89.
Crossref
Gabriela de Moraes Soares Araújo, Ana Isabel Sá Loureiro, Jamile Lima Rodrigues, Paula Alice Bezerra Barros, Priscila Cristina Bartolomeu Halicki, Daniela Fernandes Ramos, Marcelo Augusto Germani Marinho, Daniela Pastorim Vaiss, Gustavo Richter Vaz, Virginia Campello Yurgel, Juliana Bidone, Ana Luiza Muccillo-Baisch, Mariana Appel Hort, Artur Manuel Cavaco Paulo & Cristiana Lima Dora. (2023) Toward a Platform for the Treatment of Burns: An Assessment of Nanoemulsions vs. Nanostructured Lipid Carriers Loaded with Curcumin. Biomedicines 11:12, pages 3348.
Crossref
Mareike Hummert, Paul Leenders, Alexander Mellmann, Karsten Becker & Thorsten Kuczius. (2023) Generation of Plasma-Activated Fluids for Successful Disinfection of Pseudomonas aeruginosa in Liquid Environments and Determination of Microbial Damage. Plasma 6:4, pages 699-713.
Crossref
Hannah K. Gray, Omer E. Beaird, Ethan A. Smith, Joanna M. Schaenman & Shangxin Yang. (2023) Domestically Acquired NDM-1–Producing Pseudomonas aeruginosa , Southern California, USA, 2023 . Emerging Infectious Diseases 29:11.
Crossref
Miquel Àngel Sastre-Femenia, Almudena Fernández-Muñoz, María Antonia Gomis-Font, Biel Taltavull, Carla López-Causapé, Jorge Arca-Suárez, Luis Martínez-Martínez, Rafael Cantón, Nieves Larrosa, Jesús Oteo-Iglesias, Laura Zamorano, Antonio Oliver, Fátima Galán-Sánchez, Irene Gracia-Ahufinger, Luis Martínez-Martínez, Carmen Liébana-Martos, Carolina Roldán, Juan Manuel Sánchez-Calvo, Encarnación Clavijo, Laura Mora-Navas, Javier Aznar, José Antonio Lepe, Ángel Rodríguez-Villodres, Esther Recacha, Francisco Javier Casas-Círia, Carmen Martínez-Rubio, Marco Antonio Sempere-Alcocer, Lina Martín-Hita, Cristina Seral, Ana Isabel López-Calleja, Carmen Aspiroz, Marisa Monforte, Pedro de la Iglesia-Martínez, Gemma Jimenez-Guerra, Elena Riera-Pérez, Carmen Collado, Carmen Gallegos, Xavier Mulet, Almudena Fernández-Muñoz, Miquel Àngel Sastre-Femenía, María Antonia Gomis-Font, Laura Zamorano, Antonio Oliver, María Siller-Ruiz, Jorge Calvo, Dolores Quesada, Jun Hao Wang, Cristina Pitart, Francesc Marco, Nuria Prim, Juan Pablo Horcajada, Eduardo Padilla, Ester Del Barrio-Tofiño, Belen Viñado-Pérez, Nieves Larrosa, Fe Tubau, Silvia Capilla, Antonio Casabella, Mar Olga Pérez-Moreno, Emma Padilla, Mónica Ballestero, Alba Rivera, Ferrán Navarro, Fréderic Gómez-Bertomeu, Sergio Pardo-Granell, Ester Picó-Plana, Dolores Guerrero, Carolina Sarvisé-Buil, Alba Belles-Belles, Marta Fernández-Esgueva, María del Pilar Ortega-Lafont, Inmaculada García, Noelia Arenal-Andrés, Susana Hernando-Real, Rosario Ibáñez, Jesús Martínez, Federico Becerra, Carmen Aldea-Mansilla, Asmaa Alaoui-Sosse, José Carlos González, Julia Guzman-Puche, Miguel Ángel Blázquez-Andrada, Nora Mariela Martínez-Ramírez, Alicia Beteta, Bárbara Gomila-Sard, Salvador Giner Almaraz, Eugenio Garduño, Pedro Miguel Juiz-González, Jorge Arca-Suárez, Javier Alba, Pilar Alonso, Ana Isabel Rodríguez, María Isabel Paz-Vidal, Marta García-Campello, Pablo Camacho, María de los Ángeles Pallarés, María Luisa Pérez del Molino, Amparo Coira, Gema Barbeito, Anniris Rincón, Francisco José Vasallo-Vidal, Laura Alonso-Acero, Laura Iglesias-Llorente, Ana Bordes-Benites, Laura Florén-Zabala, José Manuel Azcona, Carla Andrea Alonso, Yolanda Sáenz, Marta Lamata-Subero, David Molina, Ana González-Torralba, Jennifer Villa, Esther Viedma, Emilia Cercenado, Teresa Alarcón, Paula Vargas, María Díez, Rafael Cantón, Patricia Ruiz, María Isabel Sánchez-Romero, Felipe Pérez-García, Genoveva Yagüe-Guirao, Amaia Concepción Oteiza, José Leiva, María Eugenia Portillo, Andrés Canut-Blasco, Matxalen Vidal, Iker Alonso, Maider Zuriarrain & José Luis Barrios-Andrés. (2023) Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis. The Lancet Regional Health - Europe 34, pages 100736.
Crossref
Cong Shen, Jinxiang Zeng, Dexiang Zheng, Yinglun Xiao, Jieying Pu, Li Luo, Hongyun Zhou, Yimei Cai, Liling Zhang, Meina Wu, Xuan Zhang, Guangyuan Deng, Song Li, Qiwei Li, Jianming Zeng, Zhaohui Sun, Bin Huang & Cha Chen. (2023) Molecular epidemiology and genomic dynamics of Pseudomonas aeruginosa isolates causing relapse infections . Microbiology Spectrum 11:5.
Crossref
Daniela Minerdi, Davide Loqui & Paolo Sabbatini. (2023) Monooxygenases and Antibiotic Resistance: A Focus on Carbapenems. Biology 12:10, pages 1316.
Crossref
Hamid Vaez, Zahra Yazdanpour, Farzad Khademi & Abbas Pishdadian. (2023) Prevalence and Antibiotic Resistance Patterns of Metallo-Beta-Lactamase-Producing Pseudomonas aeruginosa Isolated from Patients in a Hospital in Zabol, Southeast of Iran. Infection Epidemiology and Microbiology 9:3, pages 201-208.
Crossref
Xuan Wu, Lu Yang, Yige Wu, Hui Li & Bing Shao. (2023) Spread of multidrug-resistant Pseudomonas aeruginosa in animal-derived foods in Beijing, China. International Journal of Food Microbiology 403, pages 110296.
Crossref
Jennifer D. Bowling, Hannah K. Gray, Esther Vaugon & Lucas J. Osborn. (2023) A Day in the Life of a Medical Microbiology Fellow: Four Perspectives. Clinical Microbiology Newsletter 45:19, pages 159-166.
Crossref
Pabllo Antonny Silva Dos Santos, Marcos Jessé Abrahão Silva, Maria Isabel Montoril Gouveia, Luana Nepomuceno Gondim Costa Lima, Ana Judith Pires Garcia Quaresma, Patrícia Danielle Lima De Lima, Danielle Murici Brasiliense, Karla Valéria Batista Lima & Yan Corrêa Rodrigues. (2023) The Prevalence of Metallo-Beta-Lactamese-(MβL)-Producing Pseudomonas aeruginosa Isolates in Brazil: A Systematic Review and Meta-Analysis. Microorganisms 11:9, pages 2366.
Crossref
Beatrice Ngozi John-Onwe, Francis Amadi Ibiam, Evangeline Chinyere Udenweze, Chidinma Stacy Iroha, Christiana Inuaesiet Edemekong, Ikemesit Udeme Peter & Ifeanyichukwu Romanus Iroha. (2023) Co-expression of Extensively drug resistant (XDR) clinical isolates of Pseudomonas aeruginosa harboring FOX and MOX ampicillinase Gene. International Journal of Medical Sciences and Pharma Research 9:3, pages 14-19.
Crossref
Irene Gracia-Ahufinger, Laura López-González, Francisco José Vasallo, Alicia Galar, María Siller, Cristina Pitart, Iván Bloise, Miriam Torrecillas, Desirée Gijón-Cordero, Belén Viñado, Javier Castillo-García, Rainer Campo, Xavier Mulet, Ana Madueño-Alonso, Francisco Javier Chamizo-López, Maitane Arrastia-Erviti, Fátima Galán-Sánchez, Melisa Fernández-Quejo, Juan Carlos Rodríguez-Díaz, María Nieves Gutiérrez-Zufiaurre, Manuel Angel Rodríguez-Maresca, María del Pilar Ortega-Lafont, Genoveva Yagüe-Guirao, Lucía Chaves-Blanco, Javier Colomina-Rodríguez, María Reyes Vidal-Acuña, María Eugenia Portillo, Francisco Franco-Álvarez de Luna, María José Centelles-Serrano, José Manuel Azcona-Gutiérrez, Alberto Delgado-Iribarren García Campero, Sonia Rey-Cao, Patricia Muñoz, Jorge Calvo-Montes, Yuliya Zboromyrska, David Grandioso, Jordi Càmara, Rafael Cantón, Nieves Larrosa-Escartín, Jazmín Díaz-Regañón & Luis Martínez-Martínez. (2023) The CARBA-MAP study: national mapping of carbapenemases in Spain (2014–2018). Frontiers in Microbiology 14.
Crossref
Ying Zhu, Peiyao Jia, Wei Yu, Xiaobing Chu, Xiaoyu Liu & Qiwen Yang. (2023) The epidemiology and virulence of carbapenem-resistant Pseudomonas aeruginosa in China. The Lancet Microbe 4:9, pages e665.
Crossref
Răzvan Lucian Coșeriu, Anca Delia Mare, Felicia Toma, Camelia Vintilă, Cristina Nicoleta Ciurea, Radu Ovidiu Togănel, Anca Cighir, Anastasia Simion & Adrian Man. (2023) Uncovering the Resistance Mechanisms in Extended-Drug-Resistant Pseudomonas aeruginosa Clinical Isolates: Insights from Gene Expression and Phenotypic Tests. Microorganisms 11:9, pages 2211.
Crossref
Meha Fethi, Beatriz Rojo-Bezares, Ameni Arfaoui, Raoudha Dziri, Gabriela Chichón, Farouk Barguellil, María López, Mohamed Selim El Asli, Paula Toledano, Hadda-Imen Ouzari, Yolanda Sáenz & Naouel Klibi. (2023) High Prevalence of GES-5 Variant and Co-Expression of VIM-2 and GES-45 among Clinical Pseudomonas aeruginosa Strains in Tunisia. Antibiotics 12:9, pages 1394.
Crossref
Isabella A. Tickler, Diane Kawa, Anne E. Obradovich, Ferric C. Fang & Fred C. Tenover. (2023) Characterization of Carbapenemase- and ESBL-Producing Gram-Negative Bacilli Isolated from Patients with Urinary Tract and Bloodstream Infections. Antibiotics 12:9, pages 1386.
Crossref
Yu-Lin Lee, Wen-Chien Ko & Po-Ren Hsueh. (2023) In vitro activities of ceftazidime–avibactam, ceftolozane–tazobactam, meropenem–vaborbactam and other comparators against Pseudomonas aeruginosa isolates with discrepant resistance to carbapenems: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2012–2021. International Journal of Antimicrobial Agents 62:2, pages 106867.
Crossref
Lijun Yin, Nana Wu, Gangfeng Yan, Lu Lu, Huimin Qian, Weijing Yang, Jian Ma, Leiyan He, Guoping Lu, Xiaowen Zhai & Chuanqing Wang. (2023) Carbapenem-resistant gram-negative bacterial prevention practice in nosocomial infection and molecular epidemiological characteristics in a pediatric intensive care unit. Heliyon 9:8, pages e18969.
Crossref
Mazen A Sid Ahmed, Hawabibee Mahir Petkar, Thoraya M Saleh, Mohamed Albirair, Lolita A Arisgado, Faiha K Eltayeb, Manal Mahmoud Hamed, Muna A Al-Maslamani, Abdul Latif Al Khal, Hussam Alsoub, Emad Bashir Ibrahim & Hamad Abdel Hadi. (2023) The epidemiology and microbiological characteristics of infections caused by Gram-negative bacteria in Qatar: national surveillance from the Study for Monitoring of Antimicrobial Resistance Trends (SMART): 2017 to 2019. JAC-Antimicrobial Resistance 5:4.
Crossref
Vasin Vasikasin, Bawornnan Panuvatvanich, Timothy M Rawson, Alison H Holmes & Worapong Nasomsong. (2023) Towards optimizing carbapenem selection in stewardship strategies: a prospective propensity score-matched study of ertapenem versus class 2 carbapenems for empirical treatment of third-generation cephalosporin-resistant Enterobacterales bacteraemia. Journal of Antimicrobial Chemotherapy 78:7, pages 1748-1756.
Crossref
Carlos R V Kiffer, Thais F T Rezende, Daniela Testoni Costa-Nobre, Ana Sílvia Scavacini Marinonio, Lucas Hidemitsu Shiguenaga, Debora Nicole Oliveira Kulek, Lavinia Nery Villa Stangler Arend, Ivson Cassiano de Oliveira Santos, Bruna Ribeiro Sued-Karam, Claudio Marcos Rocha-de-Souza, Leticia Kraft, Andre Abreu, Renata Tigulini de Souza Peral, Ana Paula D’Alincourt Carvalho-Assef & Marcelo Pillonetto. (2023) A 7-Year Brazilian National Perspective on Plasmid-Mediated Carbapenem Resistance in Enterobacterales, Pseudomonas aeruginosa , and Acinetobacter baumannii Complex and the Impact of the Coronavirus Disease 2019 Pandemic on Their Occurrence . Clinical Infectious Diseases 77:Supplement_1, pages S29-S37.
Crossref
Yongqiang Yang, Yu-Hang Yan, Christopher J. Schofield, Alan McNally, Zhiyong Zong & Guo-Bo Li. (2023) Metallo-β-lactamase-mediated antimicrobial resistance and progress in inhibitor discovery. Trends in Microbiology 31:7, pages 735-748.
Crossref
Yu-Lin Lee & Po-Ren Hsueh. (2023) Poor in vitro activity of ceftazidime/avibactam, ceftolozane/tazobactam, and meropenem/vaborbactam against carbapenem-resistant Pseudomonas aeruginosa in India: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2018–2021. Journal of Infection 87:1, pages e1-e4.
Crossref
Sisi Zhen, Yuanqi Zhao, Zhangjie Chen, Tingting Zhang, Jieru Wang, Erlie Jiang, Fengkui Zhang, Yingchang Mi, Xiaofan Zhu, Mingzhe Han, Zhijian Xiao, Jianxiang Wang & Sizhou Feng. (2023) Assessment of mortality-related risk factors and effective antimicrobial regimens for treatment of bloodstream infections caused by carbapenem-resistant Pseudomonas aeruginosa in patients with hematological diseases. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Sandip Patil, Xiaowen Chen, Shaowei Dong, Huirong Mai, Bruno Silvester Lopes, Sixi Liu & Feiqiu Wen. (2023) Resistance genomics and molecular epidemiology of high-risk clones of ESBL-producing Pseudomonas aeruginosa in young children. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Qing Yuan, Lei Guo, Bin Li, Sheng Zhang, Haiting Feng, Yan Zhang, Meihong Yu, Hangbin Hu, Hongchao Chen, Qing Yang & Tingting Qu. (2023) Risk factors and outcomes of inpatients with carbapenem-resistant Pseudomonas aeruginosa bloodstream infections in China: a 9-year trend and multicenter cohort study. Frontiers in Microbiology 14.
Crossref
Xiaotuan Zhang, Changrui Qian, Miran Tang, Weiliang Zeng, Jingchun Kong, Cheng Fu, Chunquan Xu, Jianzhong Ye & Tieli Zhou. (2023) Carbapenemase-loaded outer membrane vesicles protect Pseudomonas aeruginosa by degrading imipenem and promoting mutation of antimicrobial resistance gene. Drug Resistance Updates 68, pages 100952.
Crossref
Ilda Czobor Barbu, Irina Gheorghe-Barbu, Georgiana Alexandra Grigore, Corneliu Ovidiu Vrancianu & Mariana Carmen Chifiriuc. (2023) Antimicrobial Resistance in Romania: Updates on Gram-Negative ESCAPE Pathogens in the Clinical, Veterinary, and Aquatic Sectors. International Journal of Molecular Sciences 24:9, pages 7892.
Crossref
Vasin Vasikasin, Timothy M Rawson, Alison H Holmes & Jonathan Otter. (2023) Can precision antibiotic prescribing help prevent the spread of carbapenem-resistant organisms in the hospital setting?. JAC-Antimicrobial Resistance 5:2.
Crossref
Yasunari Kamiya, Kenichi Mishima, Tetsuji TanakaKenta Sawamura, Masaki Matsushita & Shiro Imagama. (2023) Acute osteomyelitis of the patella due to Pseudomonas aeruginosa in an immunocompetent child: A case report. Medicine 102:7, pages e33012.
Crossref
Xiaotong Qiu, Xueping Liu, Ruixue Wang, Xiao Ma, Lichao Han, Jiang Yao & Zhenjun Li. (2023) Accurate, Sensitive, and Rapid Detection of Pseudomonas aeruginosa Based on CRISPR/Cas12b with One Fluid-Handling Step. Microbiology Spectrum 11:1.
Crossref
Yingjie Song, Hong Tang & Rui Bao. (2023) Comparative analysis of five type II TA systems identified in Pseudomonas aeruginosa reveals their contributions to persistence and intracellular survival. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Stefan Wimmer, Katharina Hoff, Benedikt Martin, Martin Grewer, Laura Denni, Raquel Lascorz Massanet, Maria Valeria Raimondi, Emre F. Bülbül, Jelena Melesina, Sven-Kevin Hotop, Jörg Haupenthal, Holger Rohde, Peter Heisig, Anna K.H. Hirsch, Mark Brönstrup, Wolfgang Sippl & Ralph Holl. (2023) Synthesis, biological evaluation, and molecular docking studies of aldotetronic acid-based LpxC inhibitors. Bioorganic Chemistry 131, pages 106331.
Crossref
Haniyeh Kamyab, Narges Torkashvand, Ahmad Reza Shahverdi, Mohammad Reza Khoshayand, Mohammad Sharifzadeh & Zargham Sepehrizadeh. (2022) Isolation, characterization, and genomic analysis of vB_PaeS_TUMS_P81, a lytic bacteriophage against Pseudomonas aeruginosa. Virus Genes 59:1, pages 132-141.
Crossref
Yu Shi, Qin Cao, Jingdu Sun, Xiaofang Hu, Zhi Su, Yongchang Xu, Huimin Zhang, Lefu Lan & Youjun Feng. (2023) The opportunistic pathogen Pseudomonas aeruginosa exploits bacterial biotin synthesis pathway to benefit its infectivity. PLOS Pathogens 19:1, pages e1011110.
Crossref
Christian M Gill, David P Nicolau, Elif Aktas, Wadha Alfouzan, Lori Bourassa, Adrian Brink, Carey-Ann D Burnham, Rafael Canton, Yehuda Carmeli, Marco Falcone, Carlos Kiffer, Anna Marchese, Octavio Martinez, Spyros Pournaras, Michael Satlin, Harald Seifert, Abrar K Thabit, Kenneth S Thomson, Maria Virginia Villegas, Julia Wille, Thais Teles Freitas Rezende, Zuhal Cekin, Gulsah Malkocoglu, Desirèe Gijón, Layla Abdullah Tarakmeh, Chun Yat Chu, Christoffel Johannes Opperman, Hafsah Deepa Tootla, Clinton Moodley, Jennifer Coetzee, Sophia Vourli, George Dimopoulos, Dalya M Attallah, Giusy Tiseo, Alessandro Leonildi, Cesira Giordano, Simona Barnini, Francesco Menichetti, Vincenzo Di Pilato, Giulia Codda, Antonio Vena, Daniele Roberto Giacobbe, Lars Westblade, Armando Cardona, Lauren Curtis, Ferric Fang & Gina Thomson. (2023) Phenotypic and genotypic profile of ceftolozane/tazobactam-non-susceptible, carbapenem-resistant Pseudomonas aeruginosa . Journal of Antimicrobial Chemotherapy 78:1, pages 252-256.
Crossref
Christian M. Gill & David P. Nicolau. (2022) Carbapenem-resistant Pseudomonas aeruginosa: an assessment of frequency of isolation from ICU versus non-ICU, phenotypic and genotypic profiles in a multinational population of hospitalized patients. Antimicrobial Resistance & Infection Control 11:1.
Crossref
Holger Flick, Maria Hermann, Matthias Urban & Michael Meilinger. (2022) Nosokomiale Pneumonien und beatmungsassoziierte KrankenhauserregerNosocomial Pneumonia and Ventilator-Associated Hospital Pathogens. Anästhesie Nachrichten 4:4, pages 325-335.
Crossref
Jessica Gómez-Martínez, Rosa del Carmen Rocha-Gracia, Elena Bello-López, Miguel Angel Cevallos, Miguel Castañeda-Lucio, Alma López-García, Yolanda Sáenz, Guadalupe Jiménez-Flores, Gerardo Cortés-Cortés & Patricia Lozano-Zarain. (2022) A Plasmid Carrying blaIMP-56 in Pseudomonas aeruginosa Belonging to a Novel Resistance Plasmid Family. Microorganisms 10:9, pages 1863.
Crossref
Soraya Herrera-Espejo, Ester Del Barrio-Tofiño, Tania Cebrero-Cangueiro, Carla López-Causapé, Rocío Álvarez-Marín, José Miguel Cisneros, Jerónimo Pachón, Antonio Oliver & María Eugenia Pachón-Ibáñez. (2022) Carbapenem Combinations for Infections Caused by Carbapenemase-Producing Pseudomonas aeruginosa: Experimental In Vitro and In Vivo Analysis. Antibiotics 11:9, pages 1212.
Crossref
Dokyun Kim & Seok Hoon Jeong. (2022) Current status of multidrug-resistant bacteria. Journal of the Korean Medical Association 65:8, pages 468-477.
Crossref
Arash Sezadehghani, Sanaz Dehbashi, Hamed Tahmasebi & Mohammad Reza Arabestani. (2022) Detection of blaOXA-145, blaOXA-224, blaOXA-539, and blaOXA-675 Genes and Carbapenem-Hydrolyzing Class D β-Lactamases (CHDLs) in Clinical Isolates of Pseudomonas aeruginosa Collected from West of Iran, Hamadan. International Journal of Microbiology 2022, pages 1-10.
Crossref